Archived - 2016 Volume 42 - Canada Communicable Disease Report (CCDR)
ISSN: 1481-8531
2016 Volume 42
CCDR: Volume 42-12, December 1, 2016: Improving vaccination rates
- The long and winding road to improving immunization rates: Sharing best practices in Canada
- Vaccine acceptance, hesitancy and refusal in Canada: Challenges and potential approaches
- Immunization guidance products: Different levels of detail for different uses
- Updates to the Canadian Immunization Guide: April 2015 to October 2016
- Summary of NACI Statement: Immunization Interim Recommendations on the Use of Pneumococcal Vaccines in Immunocompetent Adults 65 Years of Age and Older
- Invasive serogroup W Neisseria meningitidis (MenW) in Ontario, Canada shows potential clonal replacement during the period January 1, 2009 – June 30, 2016
- Preparedness for Zika Virus Disease — New York City, 2016
- Candida auris, a globally emerging invasive, multidrug‑resistant fungus
- Appreciation
CCDR: Volume 42-11, November 3, 2016: Antimicrobial Resistance (AMR)
- How is an international public health threat advanced in Canada? The case of antimicrobial resistance
- Antimicrobial use and antimicrobial resistance trends in Canada: 2014
- Advancing surveillance of antimicrobial resistance: Summary of the 2015 CIDSC Report
- Advancing antimicrobial stewardship: Summary of the 2015 CIDSC Report
- At United Nations (UN), global leaders commit to act on antimicrobial resistance
- Investigation of Escherichia coli harboring the mcr-1 Resistance Gene - Connecticut, 2016
CCDR: Volume 42-10, October 6, 2016: Emerging challenges of vector-borne diseases and cities
- Introduction to emerging vector-borne disease and cities workshop proceedings
- Global spread and impacts of emerging vector-borne diseases
- Present state of common vector-borne diseases in Canada
- Vector-borne disease, climate change and urban design
- Global policy challenges for urban vector-borne disease risks
- Built environment and health
- Social and ecological impacts of the exponential increase of urban sprawl in Montréal
- Understanding how people react to risk
- Vector-borne diseases: Reconciling the debate between climatic and social determinants
- Public health intervention strategies to tackle vector-borne diseases in Quebec
- Balancing the risks and benefits of insecticide use for vector control: The Venda Health Examination of Mothers, Babies and their Environment (VHEMBE) Study
- Emerging challenges of vector-borne diseases for Canadian cities
- Vector-borne diseases, climate change and healthy urban living: Next steps
CCDR: Volume 42-9, September 1, 2016: Scientific writing
- A reporting guide for implementation science articles
- A reporting guide for qualitative studies
- A reporting guide for overviews
- Assessing vaccine safety within Ontario's Universal Influenza Immunization Program, 2012-2013 to 2014-2015
- Update regarding interim Canadian recommendations for the use of a fractional dose of yellow fever vaccine during a vaccine shortage
- Summary of the National Advisory Committee on Immunization (NACI) Statement Update on Seasonal Influenza Vaccine for 2016-2017
- Summary of the National Advisory Committee on Immunization (NACI) Statement on the Recommended Use of Hepatitis A vaccine
- Environmental Assessment for Investigational Use of Aedes aegypti OX513A
- Duration of Infant Protection Against Influenza Illness Conferred by Maternal Immunization
CCDR: Volume 42-8, August 4, 2016: Current travel risks
- Illness in Canadian travellers and migrants from Brazil: CanTravNet surveillance data, 2013-2016
- Interim Canadian recommendations for the use of a fractional dose of yellow fever vaccine during a vaccine shortage
- Canadian and international recommendations on the frequency of HIV screening and testing: A systematic review
- Outbreak of acute hepatitis B virus infection associated with exposure to acupuncture
- 2016 Summer Olympic Games in Rio de Janeiro, Brazil
- Rapid Risk Assessment: The risk of Zika virus to Canadians
- Correction for CCDR 2016;42(7) pdf
CCDR: Volume 42-7, July 7, 2016: Can we stop Measles?
- Measles surveillance in Canada: 2015
- Exploring gaps in surveillance of a small measles outbreak in Toronto, Canada
- Summary of the National Advisory Committee on Immunization's Updated Recommendations on Human Papillomavirus (HPV) vaccines: Nine-valent HPV vaccine and clarification of minimum intervals between doses in the HPV immunization schedule
- Yellow Fever in Angola and the Democratic Republic of Congo
- Recommended practices for the prevention of endoscopy-related infections
CCDR: Volume 42-6, June 2, 2016: Rabies
- The changing face of rabies in Canada
- Translocated dogs from Nunavut and the spread of rabies
- Preparing for and responding to recent incursions of raccoon rabies variant into Canada
- Northern innovation in rabies prevention and control: The Weeneebayko Area Health Authority (WAHA) dog population management pilot project
- The Canadian Rabies Management Plan: An integrated approach to the coordination of rabies activities in Canada
- Outbreak of Elizabethkingia in Wisconsin
- Confirmed cases of Elizabethkingia in western Michigan
- Human rabies - Missouri, 2014
CCDR: Volume 42-5, May 5, 2016: Zika Virus
- Canadian recommendations on the prevention and treatment of Zika virus: Update
- Investigation and management of psittacosis in a public aviary: A One Health approach
- Preparing for local mosquito-borne transmission of Zika virus in the United States
- Yellow fever in Angola
CCDR: Volume 42-4, April 7, 2016: Vaccine-Preventable Diseases
- Invasive bacterial diseases in Northern Canada, 2006-2013
- Evaluation of the enhanced Invasive Pneumococcal Disease Surveillance System (eIPDSS) pilot project
- Outbreak of Shigella sonnei in Montréal's ultra-Orthodox Jewish community, 2015
- Interim recommendations for the reporting of extensively drug resistant and pan-drug resistant isolates of Enterobacteriaceae, Pseudomonas aeruginosa, Acinetobacter spp. and Stenotrophomonas maltophilia
- Efficacy and safety of RTS,S/AS01 malaria vaccine
- The RTS,S/AS01 vaccine continues to show modest protection
- Evaluation of anthrax vaccine safety in 18-20 year olds
- Single dose tetravalent dengue vaccine
CCDR: Volume 42-S2, March 17, 2016: Syrian refugees
- Syria: Land of history, civilizations and war
- Health considerations in the Syrian refugee resettlement process in Canada
- Early observations on the health of Syrian refugees in Canada
- My experience as a Quarantine Officer welcoming Syrian refugees
- Adult asylum seekers from the Middle East including Syria in Central Europe: What are their health care problems?
- An ambitious agenda for humanity
CCDR: Volume 42-3, March 3, 2016: Infectious Disease as Chronic Disease
- Comparing the care needs of people living with and without HIV in Canadian home and long-term care settings
- Hepatitis C in Canada and the importance of risk-based screening
- Primary care pearls to help eliminate tuberculosis in Canada
- Zika virus, an emerging flavivirus, as a cause of fever and rash in a traveler returning from Central America
- Zika virus associated with microcephaly
- Extrahepatic manifestations of chronic hepatitis C virus infection
CCDR: Volume 42-S1, February 18, 2016: Social Determinants of Health
- Advancing health equity to improve health: The time is now
- Inequality-related economic burden of communicable diseases in Canada
- What can public health do to address inequities in infectious disease?
- Infectious disease, social determinants and the need for intersectoral action
CCDR: Volume 42-2, February 4, 2016: Update on STIs
- Are enteric infections sexually transmitted in British Columbia?
- Benzathine penicillin G for the management of early syphilis among HIV co-infected persons: A systematic review
- Does suppressive antiviral therapy for herpes simplex virus prevent transmission in an HIV-positive population? A systematic review
- Impact of a social media campaign targeting men who have sex with men during an outbreak of syphilis in Winnipeg, Canada
CCDR: Volume 42-1, January 7, 2016: Emerging infectious diseases